Kadcyla Interactions
There are 294 drugs known to interact with Kadcyla (ado-trastuzumab emtansine), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 56 are major, and 238 are moderate.
- View all 294 medications that may interact with Kadcyla
- View Kadcyla alcohol/food interactions (1)
- View Kadcyla disease interactions (5)
Most frequently checked interactions
View interaction reports for Kadcyla (ado-trastuzumab emtansine) and the medicines listed below.
- acetaminophen
- anastrozole
- Arimidex (anastrozole)
- atorvastatin
- atropine / diphenoxylate
- Benadryl (diphenhydramine)
- capecitabine
- carboplatin
- Compazine (prochlorperazine)
- Cymbalta (duloxetine)
- Decadron (dexamethasone)
- dexamethasone
- gabapentin
- Herceptin (trastuzumab)
- letrozole
- lorazepam
- metformin
- Neulasta (pegfilgrastim)
- omeprazole
- ondansetron
- oxaliplatin
- Perjeta (pertuzumab)
- prochlorperazine
- Synthroid (levothyroxine)
- tamoxifen
- Taxotere (docetaxel)
- Vitamin D3 (cholecalciferol)
- Xgeva (denosumab)
- Zofran (ondansetron)
- Zometa (zoledronic acid)
Kadcyla alcohol/food interactions
There is 1 alcohol/food interaction with Kadcyla (ado-trastuzumab emtansine).
Kadcyla disease interactions
There are 5 disease interactions with Kadcyla (ado-trastuzumab emtansine) which include:
Report options
More about Kadcyla (ado-trastuzumab emtansine)
- Kadcyla consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Ibrance
Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.